Phase 4 IgA Nephropathy trials recruiting now

All IgA Nephropathy trials, every phase

Phase 4 IgA Nephropathy trials

• Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
  NCT06712407 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 38 locations
• Nefecon and Ambrisentan in IgA Nephropathy
  NCT07030894 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
  NCT06676384 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 12 locations

Common questions

What does Phase 4 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.